A Randomized,Double-blind, Placebo Controlled, Multicenter Study to Evaluate the Safety and Efficacy of MT2004 Capsule in DILI Subjects

Clinical trial NCT06019936 · UNKNOWN

Trial details

NCT number: NCT06019936
Sponsor: Xi'An Aolitai Pharmaceutical Technology Co Ltd
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Drug-Induced Liver Injury Cholestatic Liver Injury Mixed Liver Injury

Start date: 2023-08-10
Primary completion: 2025-08-10
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.